The Leeds Teaching Hospitals NHS Trust

Digoxin

Digoxin

For monitoring purposes, blood should not be drawn until a steady state has been attained. This will not be achieved until 1-3 weeks after starting therapy or changing dose.

Tube 01 (SE) - Serum Gel
ID Tests&Tubes0044
Additional Information For monitoring purposes, blood should not be drawn until a steady state has been attained. This will not be achieved until 1-3 weeks after starting therapy or changing dose. Hypercalcaemia, hypomagnasaemia and hypothyroidism may increase sensitivity as will other causes of hypokalaemia e.g diarrhoea, corticosteroids, carbenoxolone. INDICATIONS FOR MONITORING:
a) Initial poor response to treatment - serum digoxin will indicate level achieved and provide guidance on dosage increase
b) Helping to confirm diagnosis of toxicity although concomitant hypokalaemia must be taken into account
c) When previous drug history is uncertain particularly in elderly patients receiving a number of drugs
d) To facilitate discontinuation of therapy
e) When renal function is deteriorating or fluctuating
f) when drugs known to interfere or interact with digoxin are started or stopped e.g Verapamil and digoxin in intractable SVT- digoxin may be used at reduced dose.
Turn Around A&E: 1 hour
Day Case: N/A
In-Patient: 6 Hours
Out-Patient: 24 Hours
GP: 24 Hours
Send to Blood Sciences Cross Site
Contact For further details please contact Leeds Pathology customer services: leedsth-tr.pathologycustomerservice@nhs.net.
Collection Con Blood must be taken at least 6 hrs after last oral dose. Intensive care units, renal unit, transplant unit, patients on IV heparin use lithium-heparin (Green with Yellow ring) tube.
Instructions for Lab Staff: Standard lab processing- No special requirements
Sample REQ Blood
Ref. Range Notes Blood Sciences Refernce ranges available through the useful information and links page:
https://www.leedsth.nhs.uk/a-z-of-services/pathology/blood-sciences/useful-information-and-links/
Units ug/L
Telepath DIG2L
ICE Codes LDIG